↓ Skip to main content

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database

Overview of attention for article published in Frontiers in Pharmacology, October 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
12 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
Published in
Frontiers in Pharmacology, October 2021
DOI 10.3389/fphar.2021.769315
Pubmed ID
Authors

Marion Allouchery, Cécile Tomowiak, Thomas Lombard, Marie-Christine Pérault-Pochat, Francesco Salvo

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 15%
Student > Doctoral Student 2 10%
Researcher 2 10%
Student > Bachelor 1 5%
Student > Ph. D. Student 1 5%
Other 1 5%
Unknown 10 50%
Readers by discipline Count As %
Medicine and Dentistry 6 30%
Biochemistry, Genetics and Molecular Biology 1 5%
Economics, Econometrics and Finance 1 5%
Nursing and Health Professions 1 5%
Unknown 11 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 June 2022.
All research outputs
#6,004,838
of 22,663,969 outputs
Outputs from Frontiers in Pharmacology
#2,323
of 15,822 outputs
Outputs of similar age
#120,722
of 435,778 outputs
Outputs of similar age from Frontiers in Pharmacology
#164
of 1,137 outputs
Altmetric has tracked 22,663,969 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 15,822 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,778 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 1,137 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.